NCT04880460View on ClinicalTrials.gov

Effect of Magnesium Supplementation in Selective Serotonin Reuptake Inhibitors Treated Major Depressive Disorder Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

November 21, 2021

Study Completion Date

November 21, 2021

Conditions

MDD

Interventions

DIETARY_SUPPLEMENT

Magnesium Glycinate tablet 200mg

Magnesium glycinate tablet 200mg twice daily orally for 8 weeks along with SSRIs

DIETARY_SUPPLEMENT

Placebo tablet 200mg

Placebo tablet 200mg twice daily orally for 8 weeks along with SSRIs

Trial Locations (1)

Unknown

Basic Science and Paraclinical Science of BSMMU, Dhaka

All Listed Sponsors

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

NCT04880460 - Effect of Magnesium Supplementation in Selective Serotonin Reuptake Inhibitors Treated Major Depressive Disorder Patients | Biotech Hunter | Biotech Hunter